Highlights
1 patent
About
Multi-parametric Single-cell Analysis Device
OneCell Medical is the developer of a multi-parametric single-cell analysis device. The company's technology is designed to simultaneously capture thousands of cells and immune-phenotype/characterize each cell as well as provide the RNA sequence of a desired target. The company's approach may be highly relevant to personalized medicine. OneCell Medical was cofounded by Technion President Professor Uri Sivan. OneCell Medical is supported by the Israel Innovation Authority's incubator program as well as Sanara Ventures and the Technion.
Identity
| Name | OneCell Medical |
|---|---|
| Slug | onecell-medical |
| Type / kind | startup |
| Crunchbase ID | onecell-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwKeT_94IDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, May 2023 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District,North District |
| HQ city | Haifa |
| HQ address | Haifa, Israel |
Web & social
| https://www.linkedin.com/company/27060673 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
BiologicalsGenesCells
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business models
B2B
Tags
biotechnologymedical-technologiesprecision-medicinetargeted-therapydiagnosticscanceroncologypersonalization
Funding
| Total raised | $1.4M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}